Keyphrases
Medication Use
100%
Beta-blockers
100%
Series Analysis
100%
Calcium Channel Blockers
100%
Time of Use
100%
COVID-19 Pandemic
100%
COVID-19 Pandemic Impact
100%
Cardiovascular Heart Disease
100%
Bendroflumethiazide
100%
Prescription Data
100%
Large Population
50%
Levy
50%
Nitrate
50%
Confidence Interval
50%
Adherence to Medication
50%
Health Behavior
50%
Clinically Significant
50%
Patient Health
50%
Statins
50%
Descriptive Statistics
50%
Primary Care Patients
50%
High Blood Pressure
50%
Financial Relief
50%
Medication Regime
50%
Diuretics
50%
Adrenoceptors
50%
Global Pandemic
50%
Patient Adherence
50%
Antiplatelet
50%
Proxy Measures
50%
Reimbursement
50%
Indapamide
50%
Ivabradine
50%
Ranolazine
50%
Access to Medicines
50%
Midodrine
50%
Statistical Variation
50%
Loop Diuretics
50%
Patient Access
50%
Adherence to Medicine
50%
Negative Parameter
50%
Background Management
50%
Colesevelam
50%
ACE Inhibitors
50%
Ezetimibe
50%
Chronic Heart Disease
50%
Doxazosin
50%
Potassium-sparing Diuretics
50%
Video Abstract
50%
Nicorandil
50%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Calcium Channel Blocker
100%
Heart Disease
100%
Bendroflumethiazide
100%
Dipeptidyl Carboxypeptidase Inhibitor
50%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
50%
Cohort Study
50%
Hypertension
50%
Adrenergic Receptor
50%
Beta Adrenergic Receptor Blocking Agent
50%
Diuretic Agent
50%
Pandemic
50%
Antiplatelet
50%
Nitric Acid Derivative
50%
Midodrine
50%
Nicorandil
50%
Indapamide
50%
Ranolazine
50%
Ezetimibe
50%
Potassium Sparing Diuretic Agent
50%
Loop Diuretic Agent
50%
Doxazosin
50%
Ivabradine
50%
Colesevelam
50%
Medicine and Dentistry
Drug Therapy
100%
Cardiovascular System
100%
Medicine
100%
Heart Disease
100%
Time Series Analysis
100%
COVID-19
100%
Calcium Channel Blocking Agent
50%
Antithrombotic
50%
Bendroflumethiazide
50%
Population
25%
Cohort Analysis
25%
Statin
25%
ACE Inhibitor
25%
Primary Health Care
25%
Analysis of Variance
25%
Adrenergic Receptor
25%
Health Behavior
25%
Beta Adrenergic Receptor Blocking Agent
25%
Pandemic
25%
Antiplatelet
25%
Nicorandil
25%
Patient Compliance
25%
Ezetimibe
25%
Loop Diuretic Agent
25%
Potassium Sparing Diuretic Agent
25%
Hypertension
25%
Indapamide
25%
Colesevelam
25%
Ivabradine
25%
Midodrine
25%
Doxazosin
25%
Diuretic Agent
25%
Nitric Acid Derivative
25%
Ranolazine
25%